FRI147 A Direct-To-Patient Primary Aldosteronism Screening Program In The United States: Implementing Guidelines Nationwide

Disclosure: J.M. Brown: Consulting Fee; Self; Bayer, Inc. B. Bacare: None. Y.M. Niebuhr: None. L.C. Tsai: None. E.E. Abel: None. B. Honzel: None. A. Vaidya: Consulting Fee; Self; Corcept Therapeutics, HRA Pharmaceuticals, Mineralys. Context: Primary aldosteronism (PA) is a prevalent but grossly unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Michelle Brown, Jenifer, Bacare, Bassil, Niebuhr, Yvonne M, Tsai, Laura C, Abel, Eva E, Honzel, Brooke, Vaidya, Anand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Cardiovascular Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554426/
http://dx.doi.org/10.1210/jendso/bvad114.659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554426/
http://dx.doi.org/10.1210/jendso/bvad114.659

Ejemplares similares